Next Week: Uncover the future of biosimilars with STAT's Ed Silverman as he hosts a discussion exploring their potential impact, if they can deliver on big health care savings, and how they might be prescribed.
He'll be on stage with a panel of industry-leading speakers:
- Alex Brill, CEO, Matrix Global Advisors
- Chris Brown, Managing partner and co-founder, Integrity Rx Partners
- Michael Gonzales, Independent healthcare consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
- Fran Gregory, PharmD, Vice president of emerging therapies, Cardinal Health
Reserve your spot today, and be ready to dive in and discuss.
Register Now
No comments